Indication

Aplastic anemia

Aplastic anemia is a rare and life-threatening hematologic disorder marked by bone marrow failure and profound peripheral pancytopenia. Read more about Aplastic anemia

21 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Aplastic anemia therapies.

Showing 10–18 of 21 drugs

Filter & compare in the drug finder →Opens the drug finder with Aplastic anemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Aplastic anemia.

Aplastic anemia is a rare and life-threatening hematologic disorder marked by bone marrow failure and profound peripheral pancytopenia.

It affects the hematopoietic system across all age groups and typically arises from immune-mediated destruction of hematopoietic stem and progenitor cells by autoreactive cytotoxic T lymphocytes, though it may also develop secondary to inherited genetic syndromes, toxic exposures, radiation, or viral infections.

The hallmark pathophysiology involves severe bone marrow hypocellularity, where fatty tissue replaces functional marrow elements, clinically manifesting as fatigue and pallor from anemia, increased susceptibility to severe infections from neutropenia, and mucocutaneous bleeding or petechiae due to thrombocytopenia.

Personalize your experience

Follow Aplastic anemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it